Showing results (861-870 of 918) with videos related to

Sort By:
Pageof 92
Contemporary Clinical Trials|July 28, 2005
Design and rationale of the Utah obesity study. A study to assess morbidity following gastric bypass surgeryTed D Adams, Erick Avelar, Tom Cloward, et al.
Science Translational Medicine|December 18, 2012
Expression of RORγt marks a pathogenic regulatory T cell subset in human colon cancerNichole R Blatner, Mary F Mulcahy, Kristen L Dennis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2016
Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host DiseaseJennifer N Brudno, Robert P T Somerville, Victoria Shi, et al.
Blood|February 22, 2013
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantationDaniel H Fowler, Miriam E Mossoba, Seth M Steinberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|December 17, 2013
Colorectal cancer screeningRandall W Burt, Jamie A Cannon, Donald S David, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Nuclear-Cytoplasmic Transport Is a Therapeutic Target in MyelofibrosisDongqing Yan, Anthony D Pomicter, Srinivas Tantravahi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|October 6, 2020
NCCN Guidelines Insights: Colorectal Cancer Screening, Version 2.2020Dawn Provenzale, Reid M Ness, Xavier Llor, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2015
High-Dose Sirolimus and Immune-Selective Pentostatin plus Cyclophosphamide Conditioning Yields Stable Mixed Chimerism and Insufficient Graft-versus-Tumor ResponsesMiriam E Mossoba, David C Halverson, Roger Kurlander, et al.
Annals of Surgery Open : Perspectives of Surgical History, Education, and Clinical Approaches|March 9, 2023
Development of the Illinois Surgical Quality Improvement Collaborative (ISQIC): Implementing 21 Components to Catalyze Statewide Improvement in Surgical CareKarl Y Bilimoria, Michael F McGee, Mark V Williams, et al.
Blood|September 24, 2013
Donor-derived CD19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantationJames N Kochenderfer, Mark E Dudley, Robert O Carpenter, et al.
Pageof 92